R&D

Rx Propellant, science and R&D infrastructure platform established by Actis, growth market investor in sustainable…

Kapiva, India’s first modern holistic Ayurvedic brand for millennials, today announced the launch of the Kapiva Innovation Fund…

As India moves into 2026, industry experts state that the next phase of growth in pharmaceuticals will depend on strengthening…

Dr Rakesh Bhasin, Head R&D (Formulations), Biocon, gave a presentation on 'The R&D playbook for complex generics'. He…

CPHI Frankfurt 2025 is all set to take the stage from October 28 to 30 at Messe Frankfurt. The three-day event is expected to draw…

IGI Therapeutics, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation (IGI), and AbbVie has announced an…

Syngene International in partnership with the Research and Innovation Circle of Hyderabad (RICH) and Biocon Foundation, announced…

The first panel discussion at FDD Conclave 2025 was on ‘Accelerating OSD innovation: From R&D to Market’. It set the tone for…

The Ahmedabad Pharma Summit 2025 brought together policymakers, industry leaders, and innovators to explore pathways for global…

Vikas Bansi, Business Director- India OTC - Himalaya Wellness, Sailesh S, Partner, Anthill Ventures, Len Monheit, CEO, Industry…